Background-Prior studies suggest that most deaths in patients undergoing percutaneous coronary intervention (PCI) are related to procedural complications. Mortality associated with PCI has steadily declined during the past decade, and the cause and circumstance of death among patients undergoing PCI in the contemporary era remain unknown.
WHAT IS KNOWN
• Previous studies of in-hospital mortality after percutaneous coronary intervention (PCI) determined that most deaths were attributable to procedural complications. • Rates of in-hospital mortality after PCI have declined over time and have remained stable over the past decade. • The leading causes of in-hospital death in patients undergoing PCI in the contemporary era are unknown.
WHAT THE STUDY ADDS
• Procedural complications accounted for only a few current in-hospital deaths after PCI in this study. • Most deaths were attributable to left ventricular failure, arrhythmia, and neurological injury. • This study suggests that most deaths after contemporary PCI may be unpreventable.
The reviewers were 2 board-certified interventional cardiologists (H.S.G. and D.S.M.) and 1 board-certified noninvasive cardiologist (A.M.B.). Physicians were blinded to operator and patient identity. Reviewers performed 4 major evaluations for each case: appropriateness of decision to perform PCI, cause of death, circumstance of death, and preventability of death.
Appropriateness of PCI
The decision to pursue PCI was evaluated based on current American College of Cardiology guidelines and recommendations. 4 -7 We devised a numeric scale to correspond to American College of Cardiology class indications for PCI. Level A or B evidencesupported use of PCI (class I indications) was to receive a score of 3. Class IIa indications (PCI potential benefit deemed to be greater than the risk of an invasive procedure) was to receive a score of 2. Class IIb indications (PCI benefit is similar to the risk of an invasive procedure) was to receive a score of 1, and class III indications (inappropriate use of PCI) was to receive a score of 0. Reviewers chose from this numeric scale for each patient based on individual judgment of the data presented to them. Current guidelines were applied retroactively to cases to adjudicate in-hospital mortality within the context of contemporary standards for appropriate intervention.
Cause of Death
Each patient's cause of death was determined to be ventricular failure (right or left), arrhythmic, neurological, respiratory, infectious, hemorrhagic/vascular, or "other." The cause of death was defined as the precipitating factor for the patient's demise, independent of the presenting problem on admission.
Circumstance of Death
The circumstance of death was ascribed to 1 of the following: 
Preventability of Death
The preventability of death was determined by each reviewer on medical record inspection, graded by 6-point Likert scale: 0 was defined as an unpreventable death; 1, slightly preventable; 2, moderately preventable; 3, mostly preventable; 4, strongly preventable; and 5, entirely or certainly preventable. We defined the concept of preventability as follows: "including or subsequent to the initial decision to perform cardiac catheterization, the managing physician could have pursued a different treatment plan, thereby impacting mortality." This was included in the instructions to reviewers with the data collection form. Examples of entirely preventable deaths include death from air embolus and fatal medication error. Examples of unpreventable deaths include in-laboratory death from cardiogenic shock despite successful PCI and anoxic brain injury resulting in neurological death after out-of-hospital cardiac arrest.
Statistical Analysis
Categorical variables are shown by frequencies as percentages. The 2 test was used to evaluate for differences in categorical demographic and procedural data between those patients who died and those who survived to hospital discharge. Continuously distributed variables are shown as mean (SD) unless otherwise specified. Continuously distributed variables were tested for differences using t tests. Interrater reliability was assessed with the Krippendorff ␣ and percentage concordance between reviewers. The Krippendorff ␣ was chosen for its ability to calculate reliability for both ordinal and nominal values, as reported in our data set. 8 The percentage concordance was reported to account for suspected high variability in cause of death for unclear cases and was adjudicated on a case-bycase basis for each variable.
For cases in which Ն2 reviewers were concordant, aggregate reviewer analysis consisted of the mean ordinal value given by evaluation across all 3 reviewers. For categorical values (prohibiting use of a mean), individual scores and percentage of 3 of 3 versus 2 of 3 reviewer concordance were calculated.
Results

Patient Variables
We reviewed 5520 patients undergoing PCI from 2001 to 2009. Eighty-five patients (1.54%) died during their index hospitalization after PCI. The mean time from PCI to death was 7.13Ϯ8.14 days. The baseline characteristics of patients who survived versus those who died are highlighted in Table  1 . As expected, patients died more frequently when presenting in cardiogenic shock, after cardiac arrest, or ventricular arrhythmias. Survivors tended to be younger and have lower rates of congestive heart failure, better left ventricular ejection fraction, less atrial fibrillation and extracardiac vascular disease (Table 1) , and higher rates of prehospital angiotensin-converting enzyme inhibitor and ␤-blocker (Table 2) use compared with nonsurvivors.
Most (82%, nϭ70) deaths occurred in patients undergoing emergent or urgent PCI. Of the patients who died, 56% (nϭ48) underwent PCI for ST-segment elevation myocardial infarction, whereas 36.4% (nϭ31) presented with cardiac arrest, ventricular tachycardia, or fibrillation; 44% (nϭ37) presented in cardiogenic shock. Most patients had either isolated left anterior descending artery lesions (nϭ31, 36.4%) or right coronary artery lesions (nϭ24, 28.2%). Interventions involved bare-metal stents in a slight majority of cases (nϭ46, 54.1%) and percutaneous coronary angioplasty alone in 15 cases (17.6%). Other procedural variables are listed in Table 2 .
PCI Indication
Of all patients who died, 92.9% (nϭ79) had class IIa or higher indications for PCI, as rated by all 3 reviewers. Reviewers rated 68.2% of deaths (nϭ58) as unpreventable or only slightly preventable. The Krippendorff ␣ for appropriateness of PCI across the 3 raters was 0.521. Six deaths (7%) were rated as mostly or strongly preventable across reviewers (Table 3) . Individual rater evaluations can be seen in Figure 1 .
Cause of Death
Two or more reviewers agreed on cause of death in 87.1% of cases (nϭ74). All 3 reviewers agreed on cause of death in 47.1% of cases (nϭ40). In disagreements over cause of death, in which the interventional cardiologists agreed (61.2%, nϭ52), the preventative cardiologist disagreed with the interventionalists' consensus only 21.2% of the time (nϭ11). The Krippendorff ␣ across all 3 reviewers for cause of death was 0.534.
Among cases with at least 2-reviewer agreement, reviewers chose left ventricular failure as the most common cause of death (40.5%, nϭ30). The second and third highest causes for death were arrhythmia and neurological complications (18.9%, nϭ14, arrhythmia; 14.4%, nϭ11, neurological) ( Figure 2A) . The cause of death is listed by individual reviewer in Figure 2B . 
Circumstance of Death
Two or more reviewers agreed on circumstance of death in 85.9% of cases (nϭ73). All 3 reviewers agreed on circumstance of death in 54.1% of cases (nϭ46). In disagreements over circumstance of death in which interventional cardiologists agreed (70.5%, nϭ60), the general cardiologist disagreed with the interventionalists' consensus only 23.3% of the time (nϭ14). The Krippendorff ␣ calculated across all 3 raters was 0.445.
In cases with at least 2-reviewer agreement, reviewers determined most death circumstance to be acute cardiac in nature (63.0%, nϭ46). Reviewers rated noncardiac as the second highest circumstance of death, at 15.5% of deaths (nϭ11). Procedural complication accounted for only 8.2% of deaths (nϭ6). Most deaths were attributed to preexisting or postprocedural disease processes (nϭ67, 91.8%) ( Figure 3A) . Figure 3B exhibits each reviewer's evaluation for circumstance of death.
Discussion
Analysis of this series of patients shows that most of the in-hospital mortality after PCI at our center is caused by ventricular failure, arrhythmia, or neurological insult. Furthermore, the causes of these deaths occurred before cardiac catheterization, stemming from initial acute cardiac insult, as opposed to complications of percutaneous intervention or postprocedural care. This is in contrast to prior analyses performed in similar patient populations by Malenka 9 and Rathore 10 and colleagues, who attributed approximately half of in-hospital mortality to procedural complications, mainly thought to be in-stent thrombosis and periprocedural myocardial infarction. Our population had only 6 cases with procedural causes of mortality, and 4 with postprocedural causes for mortality. Moreover, our reviewers widely viewed most deaths as either entirely unpreventable or only slightly preventable from the moment at which the decision was made to pursue PCI. A 53-year-old man initially presented with symptomatic angina. PCI to the LAD artery was uncomplicated during the index hospitalization, but the outpatient course was complicated by stent thrombosis, occurring 3 days after PCI. The patient presented to the ED with chest pain and ECG changes consistent with STEMI; dissection was noted on repeat angiography. The patient was treated with successful primary PCI but developed acute hypotension and bradycardia. He was supported with inotropes, an IABP, and extracorporeal membrane oxygenation. Resuscitation was complicated by splenic laceration and chest wall hematomas experienced during ACLS; TEE showed a thrombus in the left ventricle and ascending aorta. The patient died on hospital day 3. (Potential measures to prevent death include earlier recognition of edge dissection ͓eg, using intravascular ultrasonography for guidance͔.)
2
A 77-year-old man with severe aortic stenosis and stable RCA stenosis underwent successful stenting of the RCA as part of a planned hybrid PCI-aortic valve replacement procedure. The patient developed hypotension ½ hour after PCI; TTE showed pericardial effusion with tamponade. Angiography showed RCA marginal branch perforation that could not be sealed percutaneously. Pericardiocentesis was performed with high bloody output to drain. The patient was supported with inotropes and IABP placement, then taken to the operating room for emergency surgery.
The patient died intraoperatively. (Potential measures to prevent death include more aggressive endovascular treatment of the perforation and earlier identification of the perforation at the conclusion of the index procedure.)
3
A 74-year-old man with history of prior coronary artery bypass graft surgery and severe aortic stenosis underwent PCI to saphenous vein graft as part of a planned hybrid PCI-aortic valve replacement procedure. The patient developed chest pain and bradycardia after deployment of the stent, and a large type 3 perforation was seen on angiography. Perforation was successfully sealed with a covered stent, but the patient remained hypotensive; TTE showed a small effusion with RV collapse. Pericardiocentesis was attempted, with inability to drain the collection. The patient developed electromechanical dissociation and died in the catheterization laboratory despite maximal medical support. (Potential measures to prevent death include more rapid endovascular treatment of the perforation.)
4
A 52-year-old man had an anterior STEMI. He received thrombolytic therapy with full-dose reteplase at an outside hospital, arriving via transfer. The patient had persistent chest pain and ECG changes at 90 min. He underwent rescue PCI to the LAD artery. Operators opted to use abciximab because of the large thrombus burden. After PCI, he complained of a severe headache and became obtunded. Computed tomography of the head showed a large subdural hematoma with intraparenchymal bleeding. A neurosurgical evacuation was performed, but the patient did not show signs of neurological recovery. His family opted to withdraw care, and the patient died on hospital day 17. (Potential measures to prevent death include withholding use of IIb/IIIa inhibitor after administration of full-dose thrombolytics.)
5
An 83-year-old woman had rest angina. A PCI to the RCA was complicated by hypotension immediately after retraction of the balloon catheter; TTE showed pericardial effusion with tamponade. Pericardiocentesis was performed with drain placement, and repeat angiography confirmed the location of the arterial perforation. The balloon was inflated and occluded the RCA but was unable to slow bloody drainage. The patient remained hypotensive and died on the table. (A potential measure to prevent death includes more definitive endovascular treatment of the perforation.)
6
A 50-year-old man with anterior STEMI presented initially with an LAD artery infarct, underwent successful stenting, and was discharged home without complication. At home, the patient self-discontinued clopidogrel secondary to gastrointestinal distress. He presented to the ED 14 days after the procedure with abdominal pain, chest pain, and shortness of breath. The ECG showed ST elevations in anterior leads, and arteriography showed in-stent thrombosis; PTCA was performed to in-stent thrombosis. Course was complicated by hypotension in the coronary care unit. The patient was initially supported with inotropic and IABP support. His hematocrit decreased precipitously, suggesting hemorrhage; TTE was negative for pericardial effusion. The patient did not respond to aggressive blood product resuscitation, he developed severe acidemia, and experienced cardiac arrest. (Potential measures to prevent death include improved patient education on the importance of medical adherence with dual antiplatelet therapy, prompt identification of hemorrhagic complications from catheterization, and an aggressive approach to vascular repair.)
PCI indicates percutaneous coronary intervention; LAD, left anterior descending; ED, emergency department; ECG, electrocardiographic; STEMI, ST-elevation myocardial infarction; IABP, intra-aortic balloon pump; ACLS, advanced cardiac life support; TEE, transesophageal echocardiography; RCA, right coronary artery; TTE, transthoracic echocardiography; RV, right ventricle; PTCA, percutaneous transluminal coronary angioplasty.
This shift from the prior findings is an expected result of rapidly evolving periprocedural therapy for myocardial infarction. Pharmacological advances with aggressive platelet inhibition, improved stent technology, and recognition of predisposing risk factors for increased mortality have led to a decrease in periprocedural and in-hospital death. Understandably, the main efforts during the past decade have been to this effect, to reduce procedural and periprocedural morbidity and mortality. Our data would suggest that these efforts have been successful, making PCI a mature technology.
Left ventricular failure, arrhythmia, and neurological injury are the major drivers for mortality, with circumstances of death largely arising from acute cardiac processes. These findings are suggestive of a more "upstream" problem that is leading to patient death. These problems cannot be totally mitigated by PCI, and other novel strategies need to be evaluated to further improve outcomes.
The exact nature of these upstream strategies still needs to be defined, to isolate modifiable components for improvement. Reductions in time to reperfusion and shortening door-to-balloon time have not led to an expected improvement in patient outcome. 11, 12 Other possibilities include the therapies offered in the field to support patients during the initial phases of their infarct. More effective systems of triage, with a focus on shorter symptom-to-balloon time, earlier and more widespread use of therapeutic hypothermia, or upstream use of ventricular support devices, could serve to temporize patients undergoing extensive myocardial infarction and limit their extracardiac injury until reperfusion.
In addition, some patients sustain such a severe initial injury from their infarct that reperfusion is futile. Our capabilities to keep patients alive using aggressive support during transport and on arrival allow for intervention to be performed, but without change in outcome. This is represented by the significant number of "unpreventable" deaths cited by our reviewers. Ellis et al 13 demonstrated an enhanced mortality prediction model over the widely used American College of Cardiology-National Cardiovascular Data Registry mortality algorithm through the inclusion of noncardiac risk factors, such as neurological status and presentation after cardiac arrest, further supporting the increased relative importance of the circumstance of a patient's presentation compared with intraprocedural course.
Our study findings have major policy implications, especially regarding public reporting. Because total mortality after PCI is increasingly used as a publicly reported quality metric, the pressure to reduce mortality can easily translate into less frequent use of PCI in those patients who may be at higher risk of death but who stand the most to gain. There is concern that such case selection may indeed be occurring in areas that mandate public reporting of mortality. 14 Thus, there is a need to focus on preventable mortality in lieu of total mortality as a quality measure for pubic reporting and to guide payment reform.
Study Limitations
Limitations to our study include the reliance on an observational, retrospective analysis of the electronic medical record of a single center, sample size, and potential for bias in reviewer determination of cause of death. Our sample size is limited in scope, with only 85 patient deaths over a 10-year period, which attests to the improvement already seen for in-hospital mortality after PCI. We attempted to minimize reviewer bias by blinding the analyses and adjudicating outcomes by both invasive and noninvasive cardiologists. Interestingly, the invasive cardiologists tended to ascribe more deaths to procedural causes than the noninvasive cardiologists, and determined more deaths to be preventable, speaking against any proceduralist bias. Preventability, an inherently subjective metric, was a predetermined assessment for each case. We provided reviewers with a definition, as previously described, with the aim to be as inclusive as possible. The use of a Likert scale to grade the degree of preventability for each death was meant to encourage as much discrimination as possible. Acknowledging an imperfect measuring tool, we attempted to introduce as much definition and encouragement to report any deaths that may have been avoided from steps taken before, during, and after the catheterization.
In addition, the interrater reliability measures (␣ values) were low, implying a high degree of variance between reviewers. However, interrater reliability metrics may be misleading in cause-of-death analyses: the score is mainly driven by most reviewers clustering around a value in cases in which there is disagreement. In cases in which cause of death is unknown, there may be wide variability, leading to lower ␣ values. Therefore, the low ␣ values calculated for our reviewers suggest a high degree of variability in those patients in whom cause or circumstance of death was unclear. For our analysis, the percent concordance between reviewers was high (87.1% in cause of death, 85.9% in circumstance of death for Ն2 reviewers in agreement), suggesting that in most cases the cause and circumstance of death were highly agreed on.
The degree of variability in those 13% to 14% of cases in which cause of death was indeterminate exhibits the challenges of medical record review analyses, with reviewers retrospectively analyzing clinical decision making and cause and circumstance of death. There is a subjective component of our analysis that we were unable to control for. Personal experience, training, and other unidentified variables between reviewers likely affect our analysis, as highlighted by our analysis of preventability ( Figure 1 ): only interventional cardiologist reviewers found any deaths to be strongly or mostly preventable. This again speaks to the difficulties in medical record review and retrospective analysis.
Finally, our study was not designed to match those patients who experienced in-hospital mortality to those patients who may have presented with similar left ventricular dysfunction, cardiac arrest, or neurological complications and survived to hospital discharge. As such, we are unable to perform an analysis to determine specific factors that may have made the difference in outcome. This remains an important question and a ripe area for further research.
Conclusions
Our study demonstrates that procedural complications are responsible for a few current PCI-related deaths, with most deaths occurring because of upstream events. Further reductions in PCI mortality will require efforts outside of the catheterization laboratory; in patient triage, access, and postprocedural care.
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